Last week, I attended a conference hosted by EFPIA in Brussels. The presentations were well delivered, the panels insightful, and the conversations meaningful. And yet I left with a sense of restlessness. The congress focused on the latest developments in research and...
When are we truly doing good? This is a question that continually drives our organisation. As a patient advocacy group, our mission is to support cancer patients and work towards their well-being. In my view, we are doing good when we help others to flourish and...
Are clinical trials designed to benefit patients, or are they primarily intended to facilitate the registration of new medicines? Why are trials initiated by the pharmaceutical industry, physicians, and researchers—but not with patients? Patients and patient advocates...
For people living in wealthy countries, access to the best treatments and medicines is often taken for granted. While there may be debates over the cost of a drug or delays before it becomes available, most patients ultimately receive the treatment they need. This...
The first conference in Costa Rica to bring together patient advocacy and science. Topics Basic and applied cancer research in Costa Rica International collaboration in cancer research Implementation of high-tech tests for early detection and cancer treatment...
